Trial Profile
TIPRANAVIR MONOTHERAPY IN EXPERIENCED PATIENTS WITH MULTIPLE REVERSE TRANSCRIPTASE MUTATIONS A PROOF-OF-CONCEPT STUDY.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Tipranavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms MOTO
- 21 Jul 2011 New trial record